Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Enlivex Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +2 vs. Q2 2024
- Shares held
- 2.56M
- +480.6K (+23.1%) vs. Q2 2024
- Total value
- $4.31M
- +$1.35M (+45.6%) vs. Q2 2024
- New holders
- 3
- 6 more added
- Sold out
- 1
- 2 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Global Retirement Partners, LLC | 11 | $18 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 145 | $244 | 0.00% | +145 | New |
| Red Tortoise LLC | 150 | $252 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 400 | $672 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 615 | $1.03K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1,000 | $1.68K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,814 | $3.05K | 0.00% | +1,583+685.3% | Added |
| Steward Partners Investment Advisory, LLC | 3,000 | $5.04K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 3,000 | $5.04K | 0.00% | +3,000 | New |
| UBS Group AG | 3,217 | $5.41K | 0.00% | +3,201+20,006.3% | Added |
| Group One Trading, L.P. | 5,730 | $9.63K | 0.00% | −19−0.3% | Reduced |
| Wells Fargo & Company | 9,184 | $15.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,420 | $17.5K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 13,935 | $23.4K | 0.00% | +2,506+21.9% | Added |
| XTX Topco Ltd | 22,659 | $38.1K | 0.00% | −2,161−8.7% | Reduced |
| Sigma Investment Counselors Inc | 30,000 | $50.4K | 0.00% | +30,000 | New |
| Renaissance Technologies LLC | 74,789 | $125.6K | 0.00% | +3,100+4.3% | Added |
| Morgan Stanley | 245,754 | $412.9K | 0.00% | +862+0.4% | Added |
| Armistice Capital, LLC | 2,139,000 | $3.59M | 0.09% | +438,429+25.8% | Added |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |